The issue, she said, is constipation
Rapid weight loss on these medications frequently includes a meaningful loss of lean muscle alongside the fat
The evolving food and beverage landscape reveals not a challenge, but an opportunity for brands to develop creative solutions, said Patty Altman, executive vice president and practice leader, Consumer and Shopper Insights, Circana
Heres a breakdown of the potential risks: 1
Supporting studies Novo's drug candidate (UBT 251, referred to as GGG) showed a mean weight loss of 19.7% at 24 weeks in patients with obesity or who were overweight with at least one related comorbidity, compared to a placebo of 2%. No PubMed abstracts or clinical trial registry entries were recovered for UBT-251 (GGG, Novo's candidate) or the specific 19.7% weight loss at 24 weeks claim
Alpha-lipoic acid, apocynin or probiotics influence glutathione status and selected inflammatory parameters in C57/BL6 mice when combined with a low-fat diet